LEADERSHIP

Jennifer A. Johnston, Ph.D. Cofounder and CEO

Jennifer A. Johnston, Ph.D.
Cofounder and CEO

Al Garofalo
Cofounder and Head of Chemistry

David Weiner
Head of Clinical Affairs

Sarah Finley Project Management

Sarah Finley
Project Management

TBD Head of Toxicology

TBD
Head of Toxicology

May Sotthivirat, Ph.D.
Head of Formulations

Sarah Jaw-Tsai, Ph.D. Head of DMPK

Sarah Jaw-Tsai, Ph.D.
Head of DMPK

At FinsnoBio we are dedicated to bringing precisions medicines to patients with serious medical conditions.

Our core team of industry professionals and network of academic experts are working together to deliver on on the scope of therapeutic potential for genetic targets in neurodegeneration.